topoisomerase I inhibitors (Dong Kook Pharm Co)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nametopoisomerase I inhibitors (Dong Kook Pharm Co)
Drug Alias Nameterpyridine derivatives (Dong Kook Pharm Co)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA topoisomerase I inhibitors
TargetsDNA topoisomerase I
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A